Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
52.10
-1.42 (-2.65%)
At close: Jun 12, 2026
SHA:688193 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 93.78 | 97.44 | 261.58 | 609.57 | 298.93 | 197.94 |
Short-Term Investments | - | - | 29.2 | 125.66 | - | - |
Trading Asset Securities | 693.75 | 693.47 | 510.96 | 50.21 | 530.98 | - |
Cash & Short-Term Investments | 787.52 | 790.91 | 801.74 | 785.44 | 829.91 | 197.94 |
Cash Growth | 2.06% | -1.35% | 2.08% | -5.36% | 319.27% | 15.10% |
Accounts Receivable | 48.53 | 45.05 | 49.37 | 77.6 | 105.13 | 55.5 |
Other Receivables | 1.42 | 0.43 | 2.64 | 4.83 | 3.54 | 4.29 |
Receivables | 49.95 | 45.48 | 52.01 | 82.43 | 108.66 | 59.79 |
Inventory | 19.73 | 21.24 | 25.14 | 28.6 | 28.29 | 19.39 |
Other Current Assets | 32.41 | 33.03 | 5.86 | 2.67 | 5.72 | 5.42 |
Total Current Assets | 889.61 | 890.66 | 884.74 | 899.14 | 972.58 | 282.54 |
Property, Plant & Equipment | 69.66 | 73.55 | 82.22 | 92.72 | 100.91 | 87.64 |
Long-Term Investments | - | - | - | 40.77 | - | - |
Other Intangible Assets | 0.22 | 0.26 | 0.41 | 0.45 | 0.66 | 0.6 |
Long-Term Deferred Tax Assets | 19.64 | 20.11 | 20.24 | 12.96 | 9.63 | 3.23 |
Long-Term Deferred Charges | 4.88 | 5.59 | 6.74 | 8.3 | 3.73 | 3.92 |
Other Long-Term Assets | - | - | - | 0.38 | 1.21 | 0.68 |
Total Assets | 984.02 | 990.17 | 994.36 | 1,055 | 1,089 | 378.61 |
Accounts Payable | 2.31 | 2.7 | 3.04 | 4.09 | 11.38 | 9.84 |
Accrued Expenses | 6.22 | 8.43 | 55.68 | 58.65 | 65.77 | 36.96 |
Current Portion of Long-Term Debt | - | 2.7 | - | - | - | - |
Current Portion of Leases | 2.3 | - | 1.91 | 2.93 | 2.6 | 1.88 |
Current Income Taxes Payable | 2.88 | 3.43 | 0.25 | 1 | 1.12 | 2.39 |
Current Unearned Revenue | 3.57 | 6.59 | 9.01 | 5.58 | 7.33 | 9.22 |
Other Current Liabilities | 42.15 | 45.14 | 4.52 | 6.21 | 7.26 | 6.02 |
Total Current Liabilities | 59.41 | 68.97 | 74.42 | 78.45 | 95.46 | 66.31 |
Long-Term Leases | 2.72 | 3.36 | 2.33 | 4.09 | 7.91 | 2.11 |
Long-Term Unearned Revenue | 3.27 | 3.89 | 5.72 | 9.42 | 22.2 | 22.2 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.72 | - |
Other Long-Term Liabilities | 0.05 | 0.03 | 0.01 | 0.01 | 0.05 | 0.24 |
Total Liabilities | 65.45 | 76.26 | 82.48 | 91.97 | 127.34 | 90.86 |
Common Stock | 40.07 | 40.07 | 40 | 40 | 40 | 30 |
Additional Paid-In Capital | 780.01 | 779.81 | 777.44 | 773.7 | 776.23 | 135.44 |
Retained Earnings | 135.26 | 130.27 | 129.87 | 149.39 | 146.13 | 122.8 |
Treasury Stock | -35.66 | -35.66 | -35.66 | - | - | - |
Comprehensive Income & Other | -1.1 | -0.58 | 0.23 | -0.35 | -0.97 | -0.49 |
Shareholders' Equity | 918.58 | 913.91 | 911.88 | 962.74 | 961.38 | 287.75 |
Total Liabilities & Equity | 984.02 | 990.17 | 994.36 | 1,055 | 1,089 | 378.61 |
Total Debt | 5.01 | 6.06 | 4.24 | 7.02 | 10.51 | 3.99 |
Net Cash (Debt) | 782.51 | 784.85 | 797.51 | 778.42 | 819.4 | 193.95 |
Net Cash Growth | 1.94% | -1.59% | 2.45% | -5.00% | 322.47% | 15.36% |
Net Cash Per Share | 19.63 | 20.23 | 20.42 | 19.79 | 21.42 | 6.39 |
Filing Date Shares Outstanding | 38.78 | 38.3 | 38.71 | 40 | 40 | 30 |
Total Common Shares Outstanding | 38.78 | 38.3 | 38.71 | 40 | 40 | 30 |
Working Capital | 830.2 | 821.69 | 810.33 | 820.69 | 877.12 | 216.23 |
Book Value Per Share | 23.69 | 23.86 | 23.56 | 24.07 | 24.03 | 9.59 |
Tangible Book Value | 918.35 | 913.65 | 911.47 | 962.29 | 960.72 | 287.15 |
Tangible Book Value Per Share | 23.68 | 23.86 | 23.55 | 24.06 | 24.02 | 9.57 |
Buildings | - | - | 58.85 | 58.85 | 58.47 | 58.47 |
Machinery | - | - | 74.51 | 71.85 | 67.39 | 48.02 |
Construction In Progress | - | - | 0.41 | - | - | - |